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Bartonella bacilliformis, the etiologic agent o f Oroya fever, has been shown to 
package 14-kbp DNA fragments of host chromosome into bacteriophage-like 
particles (BLPs). These BLPs were isolated and purified using chloroform, DNase I, 
and ultracentifiigation. Polyclonal antiserum was raised against BLPs in a New 
Zealand white rabbit, and seroreactivity was tested on a whole cell lysate o f B. 
bacilliformis screened with the antiserum. A IZA P II genomic library o f  B. 
bacilliformis DNA was screened with collected antiserum, and multiple rounds of 
plaque purification were done to isolate recombinant clones. The DNA insert o f 
interest was recovered from the library as a recombinant phagemid, termed pLC 1, and 
used to infect the XLOLR strain ofE. coli. The size o f the insert in pLCl was 
determined to be approx. 2,800 bp, and the sequence o f the insert was determined at 
the Murdock Molecular Facility. Multiple BLAST searches o f the sequenced insert 
revealed genes encoding homologues o f three translational machinery proteins found 
in other bacteria, including elongation fector TS (tsf), ribosome recycling fector {frr), 
and uridylate kinase {pyrH). The E.coli XL-1 Blue containing the pLCl was foimd to 
synthesize a protein of 39 kDa in size. While the insert did not contain nucleotide 
sequences encoding the 32, 34, or 36 kDa capsid proteins initially sought, this work 
nonetheless characterized three novel genes o f the pathogen that are essential to 
translation.
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Chapter I 
Introduction
Bartonella bacilliformis is a Gram negative, hemotrophic bacterium (1) that 
is roughly 0.25 to 0.50 pm in width and 1.0 to 3.0 pm in length. B. bacilliformis 
parasitizes human erythrocytes and endothelial cells (2, 3). Transmission o f the 
pathogen to humans occurs through the bite o f the phlebotomus sand fly (9), a vector 
present only in high altitudes of the Andes regions of Colombia, Peru, and Ecuador 
(1). B. bacilliformis is the etiologic agent o f Oroya fever (Carrion’s disease) (4); a 
disease that exhibits two unique forms. The primary form is characterized by 
infection o f nearly all circulating erythrocytes. Resulting symptoms include a severe 
hemolytic anemia, along with fever, malaise and skin pallor (2). Lysis o f almost 80% 
o f the circulating erythrocytes is not uncommon (5). Mortality rates associated with 
this phase are nearly 40% without the administration o f proper antimicrobials (1,6). 
Progression o f the disease into the secondary (tissue) phase involves invasion of 
vascular endothelial cells and commonly manifests 1-2 months after the initial 
infection. The presence o f cutaneous hemangiomas (termed verruga peruana by the 
natives) on the face and extremities is characteristic o f  the tissue phase, and is a 
direct result o f the bacterium invading the vasculature (7). Hepatosplenomegaly, 
lymphadenopathy, and severe immuno suppression are additional complications 
frequently encountered (8). In addition, masses o f bartonellae can fill the cytoplasm 
of host cells lining the blood vessels, leading to endothelial swelling and thrombosis 
(42). The verruga stage is rarely fetal and will resolve over time. Investigation into
the pathogenic mechanisms and virulence fectors instrumental in B. bacilliformis 
invasion o f erythrocytes and endothelial cells is currently underway (2, 3, 33, 35, 36).
For over 80 years, B. bacilliformis was the only known member in the genus 
Bartonella (10). Recent advances in molecular biology have shown that the 16S 
rRNA sequences of Rochalimaea and Grahamella are homologous to B. 
bacilliformis (11, 12). Thus, a taxonomic reclassification was done to include these 
members. In addition, several novel species have since been added, the most recent 
beii^ B. clarridgeiae (13).
Among the 14 species of Bartonella currently recognized, five are known to 
be pathogenic to humans, and are the causative agents o f several emerging diseases 
(14, 37, 38, 39). Two examples, B. henselae and B. bacilliformis, are unique in that 
they produce bacteriophage-like particles (BLPs) (15). Previous electron 
microscopy studies revealed the presence of round to icosahedral extracellular 
particles o f 80 run in diameter associated with the outer surface of B. bacilliformis 
and B. henselae (15, 16). These particles package near-random, 14-kbp Bartonella 
genomic DNA fi-agments (15). The double-stranded extrachromosomal elements are 
well-protected from chloroform/DNase I treatment by the external capsid proteins 
(15, 18). Bacteriophage-like particles are similar but not identical to true 
bacteriophages in that they package host DNA into pre-formed capsid heads, but 
apparently contain no obvious genetic material from the phage (15).
BLPs are not unique to certain species o f Bartonella. Several other unrelated 
bacteria have been found to possess them (19,21). The PBSX phage o f Bacillus 
subtilis (30), and the VSH-1 phage o f Serpulina hyodysenteriae (31) are prime
examples, and the latter has been shown to undergo generalized transduction. 
Rhodobacter capsulatus, a purple non-sulfur bacterium, utilizes a small 
bacteriophage-like particle (GTA) that packages random 4.5-kbp fragments o f the 
host cell’s genome and transfers it to a recipient cell (40). With the presence o f these 
BLPs across a broad range o f different bacterial species, one could assume they share 
some common functions. Horizontal gene transfer o f  virulence determinants is one 
mechanism contributing to the development of emerging infections (14), and some 
BLPs are thought to aid in this process via transduction ( 18).
Bacteria can exchange DNA by utilizing three possible mechanisms including 
transduction, transformation, and conjugation (34). During bacterial transduction, 
bacterial DNA is abnormally encapsidated into a bacteriophage and transferred to a 
recipient cell. These phage particles are composed o f a core of nucleic acid 
surrounded by a protein coat. A phage capable of infecting bacterial cells binds to a 
receptor site on the host cell. A phage enzyme then weakens the host cell wall, 
allowing the viral nucleic acid to be “injected” into the host. After penetration of 
viral DNA, one o f two possibilities can occur, depending on whether the phage is 
temperate or lytic (41).
Lytic phages are enable of causing the destruction and death o f a bacterial 
cell. Once viral nucleic acid has entered the host bacterium, the phage genes direct 
the host’s machinery to synthesize phage proteins and nucleic acids. Some o f these 
proteins may degrade the host cell DNA, while others are structural components of 
future phages. Eventually, the intracellular viral titer reaches a critical point, and
specific enzymes are released from the phages, causing destruction o f the bacterial 
cell in a process termed lysis. These new progeny phage can now infect other cells. 
The temperate phage utilizes a different mechanism. Instead of lysing the host cell, a 
temperate phage will undergo a stage analogous to transposition, whereby its nucleic 
acid integrates into the genome of the host bacterial cell This unique characteristic 
o f ten^)erate phages allows it to reproduce along with the host DNA. This 
quiescent phage nucleic acid insert is referred to as a prophage. Temperate phages 
can replicate as a proph^e in a bacterial chromosome. Temperate phages are able to 
undergo two forms o f transduction: generalized and specialized.
Specialized transduction occurs when a certain gene or group o f genes is 
transferred via the bacteriophage to another bacterium. Specifically, the prophage 
nucleic acid is incorrectly excised from the host chromosome, allowing a portion of 
the bacterial DNA to be carried along with it. Thus, subsequent packaging o f this 
novel host DNA occurs, allowing some portion of the bacterial DNA to be included 
in the bacteriophage particle. Generalized transduction occurs when non-specific 
portions o f the bacterial chromosome are incorporated into phage heads in place of 
phage DNA. Some phage enzymes are able to degrade host DNA into small 
fragments. Since headfiil packaging is usually a random event (although previous 
studies with B. bacilliformis have shown the specificity to be much less random than 
previously thought) (16), random pieces of host DNA are incorporated into the 
capsid head. In some cases, the phage DNA is replaced almost entirely by host 
DNA. These “defective” phages can now attach to another bacterial cell and inject 
the packaged host DNA into the new bacterial cell. Homologous recombination and
allelic exchange between the transduced DNA and host bacterial chromosome can 
now occur, leading to alteration of the bacterial chromosome of the recipient. 
Transfer of antibiotic resistance genes is one possibility that can have a dramatic 
effect on the viability o f the recipient bacterium. To date, transfer o f genetic material 
via other methods such as transformation and conjugation have not been 
demonstrated in the Bartonella genus (22). While it was hypothesized that B. 
bacilliformis BLPs participate in intraspecies horizontal gene transfer via 
transduction-mediated genetic exchange, previous research was unable to definitively 
demonstrate this activity (16). Research on the structure of the BLPs oiB. 
bacilliformis has revealed the presence of three major proteins in the capsid coat 
with molecular weights o f 32, 34, and 36 kDa (16). The nucleotide sequences for 
these genes has not been elucidated to date.
Due to its nature as an emerging pathogen with newly classified species and 
subspecies, the genus Bartonella is a constant threat to human and other mammalian 
hosts. While Oroya fever was once thought to be contained within a narrow location 
around 10,000 ft, recent evidence has shown an increase in cases affecting coastal 
populations at the base o f the Andes (43). In addition, the fi-equency o f international 
travel gives this isolated pathogen more opportunity to spread to non-endemic areas. 
Thus, the mechanisms o f invasion and genetic transfer of this bacterium must be 
studied in detail.
While the initial purpose of this research was to identify the nucleic acid 
sequences encoding at least one of the 32, 34, or 36 kDa proteins of the BLP capsid, 
genomic library screening with anti-BLP antibodies resulted in recovery o f a plasmid
containing DNA sequences coding for three translational machinery proteins o f the 
host. These encoded proteins were identified via homology using a BLAST search, 
and include Uridylate kinase, Elongation fector TS, and Ribosome recycling fector.
Chapter II 
Materials and Methods
A. Growth of bacterial strains
The primary B. bacilliformis strain used in this study was JB585, a flagellin' 
{fid) mutant, kan  ̂(Battisti and Minnick, 1999) grown on heart infiision agar plates 
supplemented with 4% defibrinated sheep erythrocytes (v/v) and 2% filter-sterilized 
sheep serum (v/v) (Quad Five, Ryegate, MT). Cultures were incubated at 30°C for 4 
to 5 days at 5% CO2 . The major antibiotic used in this study was kanamycin (25 
pg/ml). All E. coli strains required for propagation o f cloned genes were grown 
overnight at 37°C in Luria-Bertani medium containing kanamycin (25 p,g/ml) (Sigma 
Chemical Co., St. Louis, MO) when required (25).
B. Purification of BLPs
Forty plates o f B. bacilliformis were grown as above, and harvested into 15 
ml SM phage buffer (28). Chloroform treatment (3% vol/vol) was then employed to 
lyse the bacterial cells. This was followed by centrifugation at 6,000 x g for 5 min to 
remove cellular debris. Removal o f any remaining viable bacteria was done by 
collecting supernatant, chloroform treating as before, and centrifuging a second time. 
DNase I was added to the resultant supernatant at a final concentration o f 2 ng/ml, 
and incubated at 37°C for 2 h. After digestion o f chromosomal DNA BLPs were
pelleted via ultracentrifugation at 100,000 x g for 2 h using a SW60 rotor, model 
1040 (Beckman, Palo Alto, California). The supernatant was decanted, and 
remaining pellets were resuspended in 150 |il o f fresh SM buffer. BLP preparations 
were stored at 4®C until needed.
C. SDS-Page AnalysisAVestern Blotting
Proteins from the BLP preparations were visualized using SDS- 
polyacrylamide gels (12.5% acrylamide) by the methods from Laemmli (29). Gels 
were stained with Coomassie brilliant blue (0.05%) for visualization o f protein bands. 
Immunoblotting was accomplished by first transferring the separated proteins from 
the acrylamide gel to a nitrocellulose membrane (26). Membranes were dried, then 
blocked in 0.3% Tween-20 and 2% non-fat skim milk in IX phosphate-buffered 
saline (PBS) at pH 7.4 for 1 h at 25°C. Membranes were then rinsed in IX PBS, and 
incubated overnight with polyclonal antiserum raised against the 32, 34, and 36 kDa 
BLP proteins. Incubation with a secondaiy antibody (horseradish peroxidase-goat 
anti-rabbit IgO) was then done for 1 h. Development was accomplished using IX 
PBS, H2 O2 , 4-chloro-1 -napthol, and methanol.
D. Inoculation of rabbit
The 32, 34, and 36-kDa capsid proteins in the BLP preparation were verified 
by SDS-PAGE analysis. Protein concentrations were measured using a bicinchoninic 
assay kit (Sigma Chemical, St. Louis, Mo.) and spectrophotometric analysis at 562 
nm. A 4 ml pre-inoculation sample of rabbit blood was obtained prior to injection.
1) Harvest B. hacilîiformis from HIBB into SM phage buffer (Approx. 0.5 ml 
buffer/plate).
2) Add CHCb to a final concentration o f 3% (v/v).
3) Centrifiige at 4,000 x g for 5 minutes to remove cellular debris.
4) Repeat step 3).
5) Incubate the resulting supernatant with DNase I (2 pg/ml) for 2 h at 37°C.
6) Centrifuge at 100,000 x g for 2 h at 37°C.
7) Discard the supernatant and resuspend the pellet in SM phage buffer.
8) Store at 4°C for up to 2 weeks.
Fig 1 Flowchart illustrating the protocol used for the purification o f BLPs from B. 
bacilliformis.
A vaccine consisting of 1.5 ml Complete Freund’s Adjuvant (CFA) (Sigma),
1.4 ml IX phosphate-buffered saline (0.01 M phosphate, 0.15 M NaCl) (150 pi lOX 
PBS, 1.35 ml DIH2 O), and 0.1 ml BLP (0.61 mg/ml) was injected into a rabbit at 3 
subcutaneous depots above the shoulders. The rabbit was then boosted after one 
month with Incomplete Freund’s Adjuvant (IFA) (Sigma), IX PBS, and BLP as 
above. Generated antiserum was then collected in 1 Occ volumes for 2 weeks after 
the booster.
£ . Genomic Library Screening
A previously-constructed B. bacilliformis ZAP Express II genomic library 
was screened with the rabbit anti-BLP antiserum. Nitrocellulose circles were laid 
over infected lawns of E. coli, removed and incubated overnight with rabbit anti-BLP 
antiserum. Positive plaques were identified through successive rounds o f plaque 
purification.
Library Titer:
The host strain XL-1 Blue MRF’ was grown overnight from a frozen stock in 
2 ml LB Mag/Mal (LB supplemented with 20 pi 20% maltose and 20 pi IM 
magnesium sulfate) at 30®C with shaking at 200 RPM. Expansion was accomplished 
by adding 0.5 ml o f the culture to 50 ml LB Mag/Mal. The culture was incubated for
2.5 h at 37°C with shaking at 200 RPM. The phage library was 10-foId serially 
diluted in SM buffer. Each dilution (1 pi) was then added to 100 pi of the host strain 
(XL-1 Blue). All samples were incubated in a 37®C water bath for 30 min. Overlays 
were then prepared by melting 3 ml of top agar in a tube and cooling to 55°C. The
10
phage/host mixture (100 pi) was added to the overlay, and poured over each LB 
plate. Plates were allowed to harden for 10 min., incubated at 37°C overnight, then 
counted the next day.
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Table 2.1 Table showing all vaccine injections and serum extractions listed with 
dates and quantities.
Procedure Amount Type Date
Pre-bleed 4 ml Blood 5/17/00
1® injection 3 ml CFA/JB585 5/17/00
2® injection 3 ml IFA/JB585 6/14/00
1® serum col 12 ml Blood 7/03/00
2® serum col 6 ml Blood 7/11/00
3® serum col 10 ml Blood 7/14/00
4® serum col 10 ml Blood 8/09/00
Booster
(w/excised bands) 4 ml IFA/JB585 9/14/00
1® serum col 10 ml Blood 9/30/00
2® serum col 12 ml Blood 10/05/00
3® serum col 10ml Blood 10/12/00
4® serum col 12 ml Blood 10/24/00
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Library screen
The phage library was diluted to 15,000 pfu per plate. The diluted 
phage (1 pi) was added to 200 pi of host XL-1 Blue and incubated at 37°C for 4 hr. 
Nitrocellulose disks were soaked briefly in 10 mM IPTG, and stored dry in empty 
petri dishes until needed. Disks were then carefully laid onto agar overlays and the 
plates incubated upside down at 37°C overnight. The next day, the plates were dried 
for 30 min. at 37°C with lids open. The plates were then cooled by inversion at 4°C 
for 30 min. Orientation of the filters was recorded by marking distinct spots through 
the circles into the agar using india ink and a probe. The nitrocellulose circles were 
carefully pulled fi*om the agar using forceps and allowed to dry protein side up for 10 
min. Probing with anti-BLP antisera was accomplished via the immunoblot protocol 
described above.
F. Excision
Positive plaques identified fi’om the library were excised in vivo using E. coli 
XLOLR and XL-1 Blue MRF’ strains, and rescued using the exassist helper phage 
per manufacturer’s instructions (Stratagene). The resulting recombinant phagemids 
were used to subsequently infect the XLOLR strain. Plaques that bound the primary 
antibody were cored out of the agar and transferred to a sterile microfuge tube 
containing 500 pi SM buffer and 20 pi chloroform. The microfiige tube was then 
vortexed in order to elute the phage particles. The tube was then incubated for 2 h a t 
room temperature. Overnight cultures o f XL-1 Blue in LB Mag/Mal and XLOLR in 
LB were prepared at 30®C. The following day, a 1:100 dilution of the overnight
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culture was prepared by adding 0.5 ml o f overnight culture to 50 ml LB. The culture 
was then grown for 3 h at 37°C to mid-log phase. This was repeated for the XLOLR 
strain. 200 pi o f the XL-1 Blue culture was then added to a 15 ml conical tube, 
along with 100 pi o f phage stock, and 1 pi o f ExAssist helper phage. The contents 
o f the tube were incubated in a 37°C hot water bath for 20 minutes. Three ml o f LB 
media was added to the conical tube, followed by incubation for 2.5 hrs. at 37°C 
with shaking at 200 RPM. The tube was then heated at 70°C for 15 min. and 
centrifiiged for an additional 15 min. at 4,000 x g (7,000 RPM). The supernatant 
was decanted into a sterile tube and stored at 4°C. Phagemids were then plated by 
adding 200 pi o f XLOLR cells to two 1.5 ml tubes. 100 pi o f phage stock was 
added to one tube, while 10 pi o f stock was added to the second tube. These tubes 
were incubated at 37°C for 15 min. 300 pi of LB was added to each tube and 
incubation was con^)leted at 37°C for 45 min. with no shaking. Finally, 100 pi from 
each tube was plated on LB/Kan plates (50 pg/ml), and incubated overnight at 37°C.
G. Manipulation of DNA
Recovery o f pure plasmid DNA from E. coli was accomplished using a 
Perfect Prep kit (EppendorQ. Protocol was followed as per manufacturer’s 
instructions.
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H. Ligation of restricted DNA
All ligations were accon^lished by standard protocol. DNA (6 pi) at a 
concentration o f 0.4 pg was added to a microfuge tube with 1 pi o f lOX ligation 
salts (40 mM Tris-Cl, 10 mM MgCb). This mixture was heated at 65°C for 2 
minutes. The mixture was then placed on ice, and 1 pi each of the following was 
added: lOX DTT (10 mM), lOX ATP (0.5 mM), and T4 DNA ügase (1 “weiss” 
U/pl). Following a quick “spin” at 14,000 RPM, the ligation was incubated at room 
temperature for 2 hrs.
I. Transformation
A culture o f E. coli strain XL-1 Blue was grown overnight at 30°C with 
shaking (200 RPM). This culture was then expanded the following day by 
transferring 1 ml into an Erlenmeyer flask containing 20 ml LB. This mixture was 
incubated for 2 hrs. at 37°C with 200 RPM shaking. The culture was then 
centrifuged for 5 min. at 6,000 RPM. The supernatant was decanted, and the 
resulting pellet was resuspended in 2 ml o f ice cold TSS (a chemical agent useful in 
opening channels in the bacterium). Competent cells were then separated into 100 pi 
aliquots in sterile Eppendorf tubes. 5 pi o f DNA of interest (recovered insert) was 
added to one aliquot. These preparations were then incubated on ice for 45 min. 
Finally, 900 pi o f TSS was added to each aliquot, and samples were incubated for 75 
min. at 37°C with shaking at 250 RPM. In order to achieve equal concentration of 
the samples, the following procedure was used. Samples o f 500 pi, 250 pi, and 100
15
were centrifuged in a tabletop centrifuge for 30 sec. at 14,000 RPM. The volume 
of the supernatant decanted was 400 pi, 150 pi, and 0 pi respectively. The resulting 
pellet was then resuspended in the remaining volume (lOOpl). This volume of 
bacterial culture was plated on LB/Kan25 plates, and incubated overnight at 37®C.
J. Nucleotide sequencing and analysis
Both strands o f DNA from the cloned DNA insert were sequenced at the 
Murdock Molecular Biology Facility at the University o f Montana. T3 and T7 sites 
on the pBK/CMV phagemid located outside the insert were used as initial primers for 
the sequence reactions. Blast 2.0 was used for database searches for homologies, 
and all sequence alignments were completed using FASTA (44), Clustal W 1.6 (45), 
and BOXSHADE 3.21 (K. Hofrnann, and M.D. Baron, 
hltD://w^u.ch.embnet.org/softwarc/BQX fonn.html. 1998).
K. Induction of E. coli XL-1 Blue cultures
All E. coli XL-1 Blue strains were grown overnight at 37°C, with shaking 
(200 RPM) using a “seed” culture of 2 ml LB, and kanamycin to a concentration of 
25 pg/ml. Cultures were then expanded on day 2 by adding 1.25 ml o f seed to 8.75 
ml of LB, and 21.9 pi of Kanamycin stock (10 mg/ml). This preparation was grown 
for 1 hr. at 37°C with shaking at 200 RPM. IPTG (10 mg/ml) was then added to 
cultures at a final concentration o f 2 mM., and incubated for 2, 3, and 4 hrs each. 
Cultures were then stored in 1 volume o f glycerol and frozen at -  80°C until needed.
16
Chapter III 
Results
A. Purification of BLPs in & bacilliformis
Figure 2 (next page) shows purified BLPs alongside a molecular weight 
marker and a total cell lysate o f B. bacilliformis. The presence of the 32, 34, and 36 
kDa bands in both the first and second lane clearly show that these proteins are 
normally present in B. bacilliformis, and are major constituents o f the BLP.
B Generation of antiserum against B, bacilliformis BLPs
Following recovery o f purified BLPs, the protein content was quantified via 
bicinchoninic acid protein kit (Sigma Chemical, St. Louis, Mo.) plus 
spectrophotometry at 562 nm. Data were graphically arranged using computer 
analysis (QuatroPro for Windows). The quantified proteins were then added to a 
vaccine preparation, as described previously, and injected into a New Zealand white 
rabbit. All antiserum recovered fi*om the rabbit was tested for immunogenicity 
against the 32, 34, and 36-kDa proteins in the B. bacilliformis BLP. Figure 3 shows 
the corresponding immunoblot to Figure 2, and contains a molecular weight marker, 
total protein profile for JB585, and the BLP preparation. Incubation with recovered 
anti-BLP antibodies fi*om serum as primary antibody, followed by subsequent 
development led to the observed pattern. The anti-BLP antibody probe recognized 
the three bands corresponding to the 32, 34, and 36 kDa proteins in the total protein 
profile and the BLP prep. This result indicates that the
17
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Fig 2. Coomassie brilliant blue-stained SDS PAGE gel (12.5% acrylamide) 
showing B. bacilliformis JB585 whole-cell lysate and BLP associated proteins. Lane 
1, B. bacilliformis JB585 whole-cell lysate showing a total protein profile; lane 2, 
protein profile o f purified BLP proteins fi'om B. bacilliformis, showing the three 
large bands at 32, 34, and 36 kDa (marked with >); lane 3, molecular mass standard 
in kilodaltons.
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Fig 3. Corresponding Western blot to Figure 2. Blotted proteins were probed with 
anti-BLP antiserum. Lane 1, 32, 34, and 36-kDa BLP capsid proteins (marked with 
>) from B. bacilliformis JB585 whole-cell lysate; lane 2, protein profile of purified B. 
bacilliformis BLPs showing the 32, 34, and 36-kDa major bands; lane 3, molecular 
weight standards (rainbow) in kilodaltons.
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recovered antiserum from the rabbit is highly specific and immunoreactive with 
respect to the three BLP proteins.
C. Cloning the genes located on pLCl
A XZAP II B. bacilliformis genomic library was screened using the anti-BLP 
antisera as the primary antibody probe, as described in materials and methods. 
Several positive plaques were isolated and the purified, and recombinant PBK/CMV 
plasmids were recovered from each E. coli clone. In addition, an SDS-PAGE gel 
(Fig 4) shows several proteins from pLCl that are not found in the lane 
corresponding to E. coli containing the control plasmid (PBK/CMV with no insert). 
The corresponding immunoblot clearly shows the position o f these immunogenic 
proteins as existing outside the 32-36 kDa range. Thus, these are not the 32, 34, or 
36 kDa proteins initially pursued in this study.
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Fig 4. Coomassie brilliant blue-stained SDS-polyacrylamide gel (12.5% 
acrylamide) of selected clones. Lane 1, molecular mass standards in kilodaltons; lane 
2, B. bacilliformis whole-cell lysate showing total protein profile; lane 3, total 
protein profile o f pBK/CMV phagemid with no insert; lane 4, protein profile of 
pLCl; lane 5, total protein profile of pLC4. Marked band (<) in lane 4 corresponds 
to 39 kDa protein encoded by recovered DNA insert.
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D. Analysis of nucleotide sequences in the insert of pLCl
Figure 5 shows the map o f the sequenced insert which contains 3 complete 
genes, 4 intergenic spacers (ITS), and part o f a fourth gene. Orientation of the genes 
was surmised from homologues identified by BLAST. Thus, the 5' end contains 
roughly 168 bp corresponding to a gene (rpsB) with homology to the 30S ribosomal 
protein S2 o f Mesorhizobium loti. The first uninterrupted gene lies 122 bp 
downstream from the S2 gene, and has 76% identity with the elongation fector-Ts 
gene from Bartonella quintana (tsf). This gene is by fer the largest in the insert, 
measuring almost a full kilobase in size (942 bp). The B. bacilliformis ts f  gene was 
found to have a 42.0 mol% G+C. The third gene is located 142 bp downstream of 
ts f  and is 720 bp long. This gene shares 64% identity with the uridylate kinase 
{pyrH) gene o f M  loti, and has a 39.1 mol% G+C. The final gene in this locus is 
located 34 bp downstream frompyrH, and is 558 bp long with a 41.0 mol% G+C. 
This gene (frr) encodes the ribosome recycling factor and shares homology with a B. 
melitensis homologue (72% identity). Transmembrane computer predictions 
(TMPred program; ISREC server) identified two potential transmembrane helices in 
mature pyrH, found at amino acids 49 to 65 and 120 to 144. The immediate function 
o f these helices is unknown, and the lack of a C-terminal phenylalanine would tend to 
discourage a role as an integral outer membrane protein (51).
Analysis for inverted repeat sequences in the four intergenic spacers was 
accomplished using PC/GENE software. Inverted repeats in these regions would be 
characteristic of potential Rho-independent transcriptional terminators. Non-
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palindromic repeats were found in three o f the four spacers, including ITSl, ITS2, 
and ITS4. The ITS3 spacer consisted o f only 34 bp, and had 2 palindromic repeats. 
Analysis o f the ITS regions for potential promoter sequences by neural network 
prediction yielded expected results. The 34 bp ITS3 contained no potential 
promoters. ITS2, which seemed the most likely candidate for containing a promoter 
region due to its relative position in the locus, had two hits. The second hit had a 
score o f 0.99 by prokaryotic promoter neural network prediction due to the presence 
o f a-TATAAT region. Finally, ITSl had 3 hits. The importance o f these findings 
will be discussed in the next chapter.
£ . Generation of a deletion mutant in E.coli
Several attempts were made at generating a truncated form of the insert by 
deletional mutagenesis. Hindlll was used to cut at the internal restriction site lying 
800 bp inside (see fig. 5). The 750-bp internal Hindlll fi'agment was excised fi'om 
the gel, gene cleaned, religated, and transformed into DH5a cells. While no results 
were generated, this experiment would have allowed us to map which of the three 
conç)lete genes on the insert encoded the gene product present as the 39-kDa band 
in the total protein profile o f B. bacilliformis.
F. Nucleotide and predicted translation of sequence from insert
Figures 6, 8, and 10 contain the con^lete nucleotide sequence and translation 
o f all three genes from the pLCl clone. These figures also display the nucleotide 
sequence. In addition, the molecular weight o f each protein encoded by these genes
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was determined using Paul Stothard's home page 
(http://www ualberta ca/-stothard/iavascript/dowTiload html)
Four-Gene Locus in Bartonella 
bacilliformis
I RM j
Fig 5. (above) Map of the rpsB-tsf-pyrH-frr locus in pLCl showing the relative 
positions o f each gene, the intergenic spacers, and the Hindlll site located in ts f  
(Following page) Map of the pBK/CMV phagemid used in the excision of the insert.
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1 ATGAGCATTACTGCTGCACAAGTAAAAGAACTTCGAGAATTATCGGGCGCTGGTATGATG 60
M S I T A A Q V K E L R E L S G A G M M
61 GATTGCAAAGCAGCTCTAATGGAAACCAATGGTGATATAGAGACTGCGGTTGACTGGCTT 1 2 0  
D C K A A L M E T N G D I E T A V D W L
1 2 1  CGCAAAAAAGGCATGGCCAAGGCAGATAAAAAGGCTGGACGTACAGCAGCTGAGGGATTA 1 8 0  
R K K G M A K A D K K A G R T A A E G L
1 8 1  ATCGGTATTGCATCTAAAGGTTTAAGTGCTGTTGTGGTTGAAGTTAATTCTGAAACAGAT 2 4 0  
I G I A S K G L S A V V V E V N S E T D
2 4 1  TTTGTTGCGCGCAACGATGCATTTCAAACAATTGTACGAAATGTGGCAACCGCTGCTTTA 3 0 0  
F V A R N D A F Q T I V R N V A T A A L
3 0 1  GATACAGAAGGTAGCGTTGAATCTGTTTCTGCATCTATTTATCCAGGTTCTGAGAAAACA 3 6 0  
D T E G S V E S V S A S I Y P G S E K T
3 6 1  GTAGAAGAAGCAATTAAGGATGCAATTGGTACAATTGGCGAGAATATGGCATTTCGTCGC 4 2 0  
V E E A I K D A I G T I G E N M A F R R
4 2 1  TCAGCTAAGTTATCTGTTCAAAATGGTGCTGTTGCTACTTATATTCATAATAGTGTTGCT 4 8 0  
S A K L 5 V Q N G A V A T Y 1 H N S V A
i
4 8 1  GATGGTCTTGGAAAGCTTGGAGTTTTAGTTGGTATTGAAACGACAGGAGATAAGGAAGTT 5 4 0  
D G L G K L G V L V G I E T T G D K E V
5 4 1  GCGGTTGATTTTGCTCGCAAAGTTGCGATGCATATTGCTGCAACTAATCCATTAGCTTTA 6 0 0  
A V D F A R K V A M H I A A T N P L A L
6 0 1  ACAGTAGCAGATGTTGATGCCAGTATTGTCGAGCGTGAAAAAGCAATTTTTTCAGATCAG 6 6 0  
T V A D V D A S I V E R E K A I F S D Q
6 6 1  GCGCGTCAGTCAGGAAAGCCTGAAAATATTATTGAGAAGATGGTAGAAGGGCGCATACGT 7 2 0  
A R Q S G K P E N I I E K M V E G R I R
7 2 1  AAATTCTACGAAGAGGTTGTTCTGCTTTCTCAGGCTTTTGTTATGAATCCTGATGTCACT 7 8 0  
K F Y E E V V L L S Q A F V M N P D V T
7 8 1  GTTGAAGCTTCTTTGAAGGATGCAGAAAAAATGATTGGAGCTCCAGCAAAAATTACAGGT 8 4 0  
V E A S L K D A E K M I G A P A K I T G
8 4 1  TTTGTTCGCTTTGCGTTGGGTGAAGGCGTAGAAAAGGAAGAGGTTGATTTTGCTGCAGAA 9 0 0  
F V R F A L G E G V E K E E V D F A A E
9 0 1  GTTGCAGCTGCCGCAAAGGGTtaatagttt t t t c g a t c a t t t a g c a g a a a t t t a a a a c t g  9 6 0  
V A  A  A  A  K G *
9 6 1  c a t t c t a a a t a a a a a a t a t a a t t a t c t g a a g g g c a t c a c g t g a c a a t g t g g t g c c c t t a g  1 0 2 0
1 0 2 1 t g t a t c g a a a a c a a a a a g t a a t g t g c t c t t t t g g a g a t t a t a t  1 0 6 4
Fig 6 Sequence o f ts f  and its encoded protein. Nucleotides within the tsf ORF are indicated with 
uppercase letters. The deduced amino acid sequence of tsf is shown below the first base o f its 
respective codon triplet. The stop codon is indicated by an astwisk. Inverted repeats constituting a 
potential p-independent terminator are underlined. The downward arrow indicates the position o f 
the Hindlll site.
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1  ATGACATTAGCTCTTCGATATAAACGTGTTTTGTTAAAAGTATCTGGTGAAGCACTTATG 60  
M T L A L R Y K R V L L K V S G E A L M
61 GGAGAACAAAGTTTTGGAATTGATGTTTCAGTTGCGGACCGTATTGCTTCTGATATTGCT 1 2 0  
G E Q S F G I D V S V A D R I A S D I A
1 2 1  GAAGTGCGAAAAATGGGTGTGGAAGTCGCTATTGTAATAGGTGGTGGTAATATTTTTCGT 1 8 0  
E V R K M G V E V A I V I G G G N I P R
1 8 1  GGGGTTGCTGTTGCTTCGCATGGTGGTGACCGTGTAACTGGTGATCATATGGGAATGCTT 2 4 0  
G V A V A S H G G D R V T G D H M G M L
2 4 1  GCAACAGCTATCAATTCTCTGGCGTTGCGAACATCATTGACGAAGCTAGGTGTTGAAACG 3 0 0  
A T A I N S L A L R T S L T K L G V E T
3 0 1  GTTGTACTCTCTGCAATTACCATGCCACAAATATGCGAAAGTTTTTCTCAGCGTAAGGCA 3 6 0  
V V L S A I T M P Q I C E S F S Q R K A
3 6 1  ATGAGCTATATGAATCAAGGAAAAGTTGTTATTTTTGCAGGTGGTACAGGTAATCCATTT 4 2 0  
M S 7 M N Q G R V V I F A 6 G T 6 N P F
4 2 1  TTTACTACTGATrCTGCTGCTACTTTACGAGCAGCAGAAATTGGTGCAGATGTTTTATTG 4 8 0  
F T T D S A A T L R A A E I G A D V L L
4 8 1  AAAGGAACACAAGTAGACGGTATTTATTCTGCTGATCCAAAGATAAATTCTACCGCTAAA 5 4 0  
K G T Q V D G I Y S A D P K I N S T A K
5 4 1  CGTTTTGATCAGCTAACGCATGTTGAAATTTTACGATTAGGATTGTCTATTATGGATACG 6 0 0  
R F D Q L T H V E I L R L G L S I M D T
6 0 1  ACAGCAGTAACTTTAGCACGTGAAAATAACATACCGATTATTGTATATTCTATTCATGAA 6 6 0  
T A V T L A R E N N I P I I V Y S I H E
6 6 1  AAAGGTGGTCTGACTAAGGTGTTAAATGGGACAGGGCGGTTTACAGTAGTATCGGAATGA 7 2 0  
K G G L T K V L N G T G R F T V V S E C
7 2 1  AAA 7 2 3
K
Fig 8 Sequence o f pyrH and its encoded protein. Nucleotides within the pyrH  ORF are indicated 
with uppercase letters. The deduced amino acid sequence o f PyrH is shown below the first base of 
its respective codon triplet. Amino acids in bold6ce indicate those identified by TMPred to be part 
o f a transmembrane helix.
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1  ATGAGTGTTACATCAATTATGGATGATCTGAAACGTCGGATGGATGGTGCTATTTCAGCT 60  
M S V T S I M D D L K R R M D G A I S A
6 1  TTTAAACACGAGTTAAGTGGTTTGCGGACTGGGCGAGCATCGGCGAGCTTGTTAGAGCCA 1 2 0  
F K H E L S G L R T G R A S A S L L E P
1 2 1  TTGACTGTTGAGGCTTATGGTTCTGTTGTTCCTATAAAACAGGTTGCAAATATTTCTGTT 1 8 0  
L T V E A Y G S V V P I K Q V A N I S V
1 8 1  CTAGAGCCACGGATGCTTTCAGTTTCTGTATGGGATAAAACGATGGTAGGAGCGGTGGAG 2 4 0  
L E P R M L S V S V W D K T M V G A V E
2 4 1  CGCGCTATTCGTGATTGTGGTTTTGGTTTGAATCCCATTGTTGATGGTATGAATTTACGT 3 0 0
r a i r d c g f g l n p i v d g m n l r
3 0 1  ATTCCTTTGCCTGAATTGAATGAAGAACGCCGTAAAGAATTGGTAAAAATCGCGCATCAA 3 6 0  
I P L P E L N E E R R K E L V K I A H Q
3 6 1  TATGCAGAACAGGCTCGTGTTGCCATCCGCCATGTTCGTCGTGATGGTATGGATAATTTA 4 2 0  
Y A E Q A R V A I R H V R R D G M D N L
4 2 1  AAAAAATTAGAAAAAGAAGGCGAAATTAGCCAAGATGAGGCTCGTAGTTTATCTGAAAAA 4 8 0
k k l e k e g e i s q d e a r s l s e k
4 8 1  GTTCAAAAACTCACAGATGACGCCATTGCTGACATTGATAAAATTCTGATTATGAAAGAA 5 4 0  
V Q K L T D D A I A D I D K I L I M K E
5 4 1  ACTGAAATTATGCAGGTT 5 5 8
T E I  M Q V
Fig 10 Sequence oîfrr  and its encoded protein. Nucleotides within the frr  ORF are indicated with 
uppercase letters. The deduced amino acid sequence o f Frr is shown below the first base o f its 
respective codon triplet.
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The EF-Ts gene {tsf) was shown to encode a protein o f molecular weight 
32.4 kDa. The other two genes encoded protein products o f smaller molecular 
weights. Uridylate kinase gene {pyrH) generated a protein product o f 25.4 kDa, and 
the protein translated from the ribosome recycling fector gene (fir) was 20.8 kDa. 
The elongation fector-Ts is actually a subunit o f  the larger Elongation factor-T. 
During the elongation phase o f translation, the EF-T combines with GTP to form the 
EF-Tu-GTP complex. The EF-Ts subunit is subsequently released, leaving the EF- 
Tu-GTP complex to bind the aminoacyl-tRNA (47). Uridylate kinase functions 
primarily as a nucleotide kinase. This enzyme is required for the generation o f UDP 
from UMP. The ribosome recycling fector is instrumental in the fourth step of 
protein biosynthesis. The primary step in this post-termination disassembly centers 
around the ribosome recycling factor. Simply, the ribosome recycling factor 
catalyzes the disassembly of the post-termination complex. This conç>lex consists o f 
the bound mRNA containing the termination codon, the deacylated tRNA bound to 
the P-site, and the ribosome itself. In sum, the recycling o f ribosomes for another 
round o f protein synthesis is accomplished (48). Figures 7, 9, and 11 are multiple 
sequence alignments generated using Boxshade and Clustal showing the closest 
homologues to these proteins in GenBank.
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B q _ E F - T S  
M l  E F - T S
B b  E F - T S  
B q _ E F - T S  
M l  E F - T S
S b _ E F - T  S 
B q  E F - T S  
M l  E F - T S
M a  X - i ' A A U  V ft  ë i .  Kid L  â  t i A G M H D  C K A A L  
M S I H A A Q V K E L  R r a L Q G A O M M O C K A A L
B b  E F - T S  1 8 1  B V D
B q _ E F - T S  1 8 1  « A V
M l  E F - T S  1 8 0  9 h a
B b _ E F - T  S 2  4 1
B q _ E F - T S  2 4 1
M l  E F - T S  2 4 0
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1 2  0  B t  D
B b _ E F - T S  
B q__ E F - T S  
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Fig 7. Multiple sequence alignment of B. bacilliformis Tsf (ef-Ts) with B. 
quintana Tsf and M loti Tsf Identical amino acid residues are noted in black, 
conserved residues in gray, and white indicates no homology. The GenBank 
accession numbers for the B. quintana and M. loti homologues are Q9XCMS and 
N P102414, respectively.
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Bb UR 1
Ml UK 1
: c_UK 1
Bb UK 5 4
Ml UK 61
C O UK 57
Bb UK 114
Ml UK 12 1
Co_UK 117
Bb UK 17 4
Ml UK 18 1
Cc_UK 177
Bb UK 234
Ml UK 24 1
:c UK 237
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Fig 9. Multiple sequence alignment o f B. bacilliformis PyrH with M  loti PyrH and 
C  crescentus PyrH. Identical amino acid residues are noted in black, conserved 
residues in gray, and white indicates no homology. The GenBank accession numbers 
for the M. loti and C. crescentus homologues are NP102410 and AAK23896, 
respectively.
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Fig 11. Multiple sequence alignment of B. bacilliformis Frr with B. melitensis Frr 
and M. loti Frr. Identical amino acid residues are noted in black, conserved residues 
in gray, and white indicates no homology. The GenBank accession numbers for the 
B. melitensis and M. loti homologues are ACCP94340 and NP 102409, respectively.
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Fig. 7 contains the amino acid sequence o f the protein product from the ts f  
gene in B. bacilliformis^ and its homologues from B. quintana and Mesorhizobium 
loti. B. quintana shares 76% amino acid identity with the TSF protein from B. 
bacilliformis^ while there is 71% identity between M  loti and B. bacilliformis 
homologues. The amino acid sequence for PyrH and nearest homologues is given in 
Fig. 8. Considerable identity (75%) was found to exist between B. bacilliformis and 
the M  loti homologue. The Caulobacter crescentus homologue also shared identity 
with B. bacilliformis (54%). Figure 10 shows that the Frr protein in B. bacilliformis 
has significant homology with Brucella melitensis (72%), and M. loti (65%).
G. Induction/expression of proteins encoded on the pLCl insert
An induction experiment involving E. coli strain XL-1 Blue harboring pLCl 
(termed B111-10) was carried out as indicated in materials/methods. Cultures were 
grown for 2, 3, and 4 hrs. respectively, and protein profiles from B. bacilliformis and 
E, coli XL-1 Blue B111-10 at each time interval were separated on a 12.5% SDS- 
PAGE gel. In addition, a negative control consisting o f E. coli containing the mother 
phagemid (pBK/CMV) without DNA insert was included for comparison. Figures 
11 and 12 clearly show a 39-kDa band in lanes 4-6 that is strongly produced when 
the B111-10 strain is grown in the presence o f IPTG. This protein band is not 
present in the mother phagemid, but is part o f the total protein profile for B. 
bacilliformis (lanes 2). These results indicate that the 39-kDa protein is a product of 
one of the genes in the cloned insert o f pLCl.
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Figure 12 Coomassie brilliant blue-stained SDS-polyacrylamide gel (12.5% 
acrylamide). Lane 1, molecular weight standards in kilodaltons; lane 2, B. 
bacilliformis JB585 whole-cell lysate showing a total protein profile; lane 3, total 
protein profile o f pBK/CMV phagemid; lanes 4-6, total protein profile o f pLCI after 
induction with IPTG 2, 3 and 4 hours, respectively. Marked band indicates an insert- 
specific protein at approx. 39 kDa. ______________________________
34
kDa
Zlfj-
129-
91 - 
43 -
39-
18-
: -I. viÿ.#:-
r /  ;
k " -Ci
i .
,'W-sv .-;v
' li - - ' '• I.'-'- '
v 'r k tm
'V ':4 .
Figure 13 Corresponding Western blot to Figure 12. Blotted proteins were probed 
with anti-BLP antiserum. The 39 kDa bands in lanes 4-6 are clearly recognized by 
the antibody, as are the 32, 34, and 36 kDa proteins in lane 2.
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Chapter IV 
Discussion
Bartonella bacilliformis is an invasive, Gram negative intracellular parasite of 
human erythrocytes and endothelial cells. While this bacterium has been traditionally 
limited to a narrow range of altitude in the Andes mountains, there are two dangers. 
First, at least twelve species o f Bartonella are found worldwide. In addition, at least 
one case of Oroya fever has been recorded along the coastal regions o f Peru, far 
removed from its endemic region (43). Of the twelve aforementioned species, five 
pose a significant health threat to humans and are the cause o f a number o f emerging 
diseases. Horizontal transfer o f virulence genes via transduction-mediated exchange 
is one possible mechanism contributing to the rise in emergent infectious 
bartonellosis.
While the initial purpose of this study was to characterize genes encoding the 
32, 34, or 36-kDa BLP capsid proteins, genomic screening instead recovered a 2.8- 
kbp DNA insert containing part of a locus o f genes encoding translational machinery 
proteins of the host bacterium. This locus consisted o f three complete genes, three 
complete intergenic spacers, one inconqjlete gene, and part o f  a fourth intergenic 
spacer region. Multiple BLAST searches o f the sequenced DNA identified genes 
with homology to elongation factor Ts from Bartonella quintana, 30S ribosomal 
protein from Mesorhizobium loti, and both uridylate kinase and ribosome recycling 
factor from Brucella melitensis.
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Based upon the many attempts at screening the same genomic library (~ a 
dozen times), and the discovery o f a locus o f genes rather than the BLP capsid genes, 
it is safe to theorize that the particular 32, 34, and 36 kDa proteins in question 
cannot be recovered in a n f . coli XLOLR strain. One potential reason for this 
problem could be that the recombinant capsid proteins are somehow toxic to E. coli, 
thus preventing bacterial growth
The BLPs from B. bacilliformis were initially purified with the intent of 
producing polyclonal antiserum to be used for screening genomic libraries. The 
purification scheme, discussed earlier, was accomplished using a kan  ̂strain, JB585. 
This strain was chosen for two reasons. First, JB585 contains the neomycin 
phosphotransferase gene. This is useful as it confers kanamycin resistance. In 
addition, JB585 is also a fiagellin (ild^ strain, which prevents flagella contamination 
during BLP preparation. Figure 2 clearly shows the presence of the 32, 34, and 36 
kDa bands in lanes 2 and 3. These data suggest that these proteins are present in the 
BLP and that the BLP exists in the B. bacilliformis lysate. The vaccine containing 
purified BLPs was administered to the rabbit via the schedule shown in table 2.1. In 
total, more than 25 ml o f antiserum were recovered over a 6-month span. Figure 3 is 
a Western blot showing the specificity o f this antiserum and its reactivity to both a 
purified preparation o f BLPs, and a total cell lysate o f B. bacilliformis. In addition 
to being a cornerstone of this project, the generated antisera will prove to be an 
important research tool in future library screenings.
Multiple attençts were made at screening the XZAPII genomic library with 
the polyclonal antisera generated above. Recovered plaque DNA was screened by
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initiai restriction digestion with Hind[\\^ and those with inserts retained. One clone 
contained two fragments of roughly 5,800 bp and 1,900 bp. Thus, we concluded 
from these data that since the pBK/CMV phagemid has a size of 4,512 bp, the 
recovered clone (termed pLCl) consisted of the mother plasmid and a 2,800-bp 
insert. Adding the approximate sizes o f the fragments yields a value o f 7,700 bp. 
While this doesn’t exactly match the value of 4,512 bp, there is actually a third 
fragment generated when pLCl is cut with HindiW. An analysis of the restriction 
sites on the insert (http://www.uaIberta.ca/~stothard/javascript/rest_trans_map.html) 
shows that in addition to the HindYW site at nucleotide 784 o f the insert, there is a 
second site at nucleotide 1,076. Thus, a 300-bp fragment is being generated that is 
not within resolution o f thel% agarose gel.
An SDS-PAGE gel/immunoblot o f pBK/CMV and pLCl screened with anti- 
BLP antiserum is shown in Figure 4. There is at least one band at approximately 39 
kDa which is recognized by the antibody. This band is also present in the total 
protein profile for B. bacilliformis^ but is difficult to see on the accompanying 
immunoblot (not shown). In addition, the band is not in the pBK/CMV control lane, 
suggesting that it is insert-specific.
The insert o f pLCl was sequenced at the Murdock Molecular Biology facility 
at the University of Montana using the T3 and T7 promoters on the pBK/CMV 
phagemid as initial primer with growing sequence used to walk the insert DNA. 
Returned sequence was then converted to PASTA format, and BLAST searches 
were accomplished using (http://www.ncbi-nlm.nih.gov/blast/Blast.cgil.
38
The EF-Ts gene {tsj) was shown to encode a protein o f molecular weight 32.4 kDa. 
The other two genes encoded protein products o f smaller molecular weights. 
Uridylate kinase gene ipyrH) generated a protein product o f 25.4 kDa, and the 
protein translated from the ribosome recycling fector gene {frr) was 20.8 kDa. The 
elongation fector-Ts is actually a subunit of the larger Elongation fector-T. During 
the elongation phase o f translation, the EF-T combines with GTP to form the EF-Tu- 
GTP con^lex (see Fig. 13). The EF-Ts subunit is subsequently released, leaving the 
EF-Tu-GTP complex to bind the aminoacyl-tRNA (47).
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Figure 14 The interaction between EF-Ts and EF-Tu during translation.
Uridylate kinase functions primarily as a nucleotide kinase. This enzyme is 
required for the generation of UDP from UMP. The ribosome recycling factor is 
instrumental in the fourth step o f protein biosynthesis. The primary step in this post­
termination disassembly centers around the ribosome recycling fector. Simply, the
39
ribosome recycling fector catalyzes the disassembly o f the post-termination complex. 
This complex consists of the bound mRNA containing the termination codon, the 
deacylated tRNA bound to the P-site, and the ribosome itself. In sum, the recycling 
of ribosomes for another round o f protein synthesis is accomplished (48).
The orientation o f the genes found on the locus (see Fig 5) for B. 
bacilliformis appears to be unique. Four genes are present in the sequence, including 
rpsB (encoding the 30S protein S2), ts f  (EF-Ts), pyrH  (UK), and frr  (RRF). Each of 
these genes has an intergenic spacer o f variable length set between them. When 
compared to the same gene cluster in other bacteria, there are some interesting 
similarities. First, it has been shown that an evolutionarily conserved locus o f genes 
exists in Lactococciis lactis (46), which consists ofpyrH  (UK) and frr  (RRF). The 
promoter for this cluster lies upstream o f an open reading frame (orf\) o f unknown 
function. The two genes lie downstream o f o r f^  in the same orientation as they 
appear in B. bacilliformis. Another common gene cluster that has been identified in
E. coli contains the rpsB gene and the ts f  gene. A promoter that lies upstream of 
rpsB serves both o f these genes. Again, the orientation o f this cluster is identical to 
the four-gene cluster in B. bacilliformis. Since the two separate gene clusters just 
discussed are evolutionarily highly conserved, it is safe to theorize that there is one 
promoter for the pyrH!frr genes, and another for the rpsB and tsf genes. Another 
possibility is that only one promoter exists for all four genes. Analysis o f the 
nucleotide base sequence o f the insert in pLCl was accomplished using PC/GENE 
software. The three intergenic spacer regions were entered, and the amount o f non- 
palindromic repeats (nprs) was determined. Non-palindromic repeats are
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characteristic of rho-independent termination sequences. These sequences contain 
multiple repeats that interact to form a secondary structure resembling a stem-loop.
It is theorized that RNA polymerase reaches this stem-loop and is slowed to the 
point of cessation (47). ITS 3, which was only 34 bp long, had no nprs. Thus, the 
pyrH  and frr  genes may be transcribed from the same promoter.
The ITS 1 region was analyzed for both non-palindromic repeats and 
likelihood o f promoter regions. PC/GENE software determined that ITS 1 had six 
nprs o f sizes 6-8 bp. In addition, there were three possible promoter predictions with 
scores o f 0.94 or above by neural network prediction. The ITS 2 region, which lies 
between ts f  and pyrH, seemed to be the most logical place for a promoter region. 
Both gene clusters in E. coli and L  lactis terminated at some point downstream from 
tsf, or upstream o f the pyrHlfrr genes. The cluster in E. coli contained only the rpsB 
and ts f  genes, while the L. lactis cluster had a separate promoter, controlling 
transcription of the pyrH  and frr  genes. Regardless, I theorized that there should be 
both a strong promoter for the pyrH  and frr  genes in ITS 2. PC/GENE results 
showed nine nprs in this region, characteristic o f some strong termination. Second, 
there were two possible promoter sequences discerned. One had a relative score of
0.92, but the second region was much more impressive. This possible promoter had 
a score o f 0.99, making ITS 2 the most likely place in all three intergenic regions 
where a promoter was to be found. This 0.99 sequence contained the standard 
TATA box about 75 bp upstream from the start ofpyrH. Thus, it is likely that there 
are two separate promoters in this four-gene cluster from B. bacilliformis. An 
unidentified promoter controls transcription o f the rpsB and ts f  genes (as well as
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other genes upstream), and a second promoter in the ITS 2 region is responsible for 
pyrH  and frr.
From the data presented, it is not possible to accept this explanation 
completely. Since we are dealing with computer-generated algorithms, and not 
experimental data, the strength of the argument is tepid at best.
Translation and alignment with nearest relatives constitutes the brunt of 
Figures 6-11. The frr  gene was shown to code for a protein o f 239 amino acids and 
molecular weight o f 25.4 kDa. This protein had greatest similarity (77.6%) and 
identity (72%) to B. melitensis. The pyrH  gene encoded a protein o f 186 amino acids 
and molecular weight o f 20.8 kDa, with greatest similarity (76%) and identity (64%) 
with M. loti. For the ts f  gene, a polypeptide containing 307 amino acids and having a 
molecular weight o f 32.5 kDa was translated from the nucleotide sequence. The 
most closely related protein was the Tsf foimd in B. quintana (84.6% similarity). Tsf 
in B. bacilliformis had 260 matches out of a total 307 amino acids with B. quintana 
(76% identity). This would most likely be the band that was visible at 39 kDa via 
SDS-PAGE analysis. As stated earlier, attempts at deleting part o f the pLCl insert, 
and re-introducing it into E. coli via transformation ended in M ure. Since this 
deletion would have inactivated tsf, it would have proven beyond a doubt the relative 
position o f the protein product o f tsf'm the protein profile.
The intensity of the insert-specific protein bands in the induction experiment 
(Fig. 12) was strong, demonstrating that the genes on the insert were both in the 
correct frame and direction relative to the lacZ gene. This result is important since it
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helps lis to visualize which bands on the SDS-PAGE gel/immunoblot are 
representative of the insert-specific genes.
In conclusion, the initial intent of this research was to identify and 
characterize at least one o f the genes encoding the 32, 34, and 36 kDa BLP proteins 
in B. bacilliformis. While we were unable to correctly locate the appropriate insert 
fi'om genomic library screenings corresponding to these proteins we did, however, 
identify a novel operon locus fi’om B. bacilliformis. The arrangement o f the genes, 
rpsB-tsf-pyrH-frr, is similar to that reported in E.coli and P. aeruginosa (50). This 
locus contained four genes essential for protein translation in the pathogen. Possible 
future work may involve a more careful study o f the genes in the locus (Le. repeat 
generation of the deletion mutants-also chromosomal walking upstream of the rpsB 
gene) in order to better characterize the genes and their protein products. In 
addition, over 25 ml o f polyclonal antiserum was generated against the purified 
BLPs. This useful tool can be utilized for future attempts at locating an insert fi’om 
the genomic library that may contain the genes initially sought after.
43
Acknowledgements
I would like to thank the members o f my thesis committee (Drs. Michael 
Miimick, D. Scott Samuels, and Keith Parker). Dr. Michael Minnick, my mentor, 
has taught me more about scientific research than he will ever know. His patience 
with my many mistakes and mishaps is greatly appreciated, and I am surely indebted 
to him. Thanks to Laura Smitherman, our talented Senior Research Assistant, for 
answering all my questions, no matter how mundane. I would also like to thank our 
other graduate student. Sherry Coleman, for all the time she took in sharing her vast 
knowledge with me. Finally, thanks to Patty McIntyre (Murdock Molecular Facility) 
for sequencing the pLCl insert.
This research was fimded by NIH grant # AI45534.
44
References
1. Krier, J.P. and M.Ristic. 1981. The biology o f hemotrophic bacteria. Armu. 
Rev. Microbiol. 35:325-338.
2. Benson, L. A., and G.M. Ihler. 1986. o f Bartonella bacilliformis \nXo 
erythrocytes. Infect. Immim. 54:347-353.
3. McGinnis-Hill, E., A. Raji, and M.S. Venezuela. 1992. Adhesion to and 
invasion of cultured human cells by Bartonella bacilliformis. Infect. Immun. 
60:4051-4058.
4. Garcia-Caceres, U., and F.U. Garcia. 1991. Bartcnellosis: an 
immunodepressive disease and the life o f Daniel Alcides Carrion. Am. J. Clin. 
Pathol. 95:S58-S66.
5. Hurtado, A., J.P. Musso, and C. Merino. 1938. La anemia en la enfermada 
de Carrion (verruga perruana). Ann. Fac. Med. Lima 28:154-168.
6. Gray, G.C., A. A. Johnson. 1990. An epidemic of Oroya fever in the Peruvian 
Andes. Am.J. Trop. Med. Hyg. 42:215-222.
7. Garcia, F.U., and J. Wojta. 1990. Bartonella bacilliformis 
endothelial cells in vitro and is angiogenic in vivo. Am J. Pathol. 136:1125- 
1135.
8. Herrer, A. 1953. Carrion’s disease. W.VxQS&ncQ o f Bartonella bacilliformis m. 
the peripheral blood o f patients with the benign form. Am. J. Trop. Med. 
2:645-649.
45
9. Hertig, M. 1942. Phlebotomus and Carrion’s disease. Anx J. Trop. Med. 
22:1-76.
10. Barton, A. 1909. Description de elementos endoglobulares en los enfermos de 
Fiebre de Verruga. Cron. Med. Lima. 26:7.
11. Brenner, D.J., S.P. O’Connor, and H, Winkler. 1993. Proposals to unify 
the genera Bartonella and Rochalimaea^ with descriptions of Bartonella 
quintana comb, nov., Bartonella vinsonii comb, nov., Bartonella henselae 
comb, nov., and Bartonella elizabethae comb, nov., and to remove the femily 
Bartonellaceae from the oràQV Rickettsiales. Int. J. Sys. Bacteriol. 43:777-786
12. Birtles, R.J, and T.G. Harrison. 1995. Proposals to unify the genera 
Grahamella and Bartonella^ with descriptions o f Bartonella talpae comb, nov., 
Bartonellaperomysci comb, nov., and three new species, Bartonella grahamii 
sp. Nov., Bartonella taylorii sp. Nov., and Bartonella doshiae sp. Nov. Int. J. 
Sys. Bacteriol. 45:1-8.
13. Lawson, P.A., and M.D. Collins. 1996. Description o f
clarridgeiae sp. Nov. isolated from the cat of a patient with Bartonella henselae 
septicemia. Med. Microbiol. Lett. 5:64-73.
14. Anderson, B.E., and M.A. Neuman. 1997. spp. as emerging
human pathogens. Clin. Microbiol. Rev. Vol. 10, No. 2:203-219.
15. Anderson, B., C. Goldsmith, and A. Johnson. 1994. Bacteriophage-like 
pecriiclQ o f Rochalimaea henselae. Mol. Microbiol. 13:67-73.
16. Barbian, K., and M. Minnick. 2000. A bacteriophage-like particle from 
Bartonella bacilliformis. Microbiology. 146:599-609.
46
17. Anderson, B., Scotchlas, D., and A. Johnson. 1997. Analysis o fa  36 kDa 
protein (PapA) associated with the bacteriophage-like particle o f Bartonella 
henselae. DNA and Cell Bio. 16(10):1223-1229.
18. Bowers, T.J., Sweger, D., and B. Anderson. 1998. Isolation, sequencing, 
and expression o f the gene encoding a major protein from the bacteriophage 
associated Bartonella henselae. Gene 206:42-45.
19. Yarmolinsl^, M.B., and N. Sternberg. 1988. Bacteriophage PI. Pg, 395- 
406. The Bacteriophages, edited by R. Calendar. Plenum Press, New York.
20. Mitchell, S.J., and M.F. Minnick. 1997. A carboxy-terminal processing 
protease gene is located immediately upstream o f the invasion-associated locus 
from Bartonella bacilliformis. Microbiology (143): 1221-1233.
21. Patek, M., Ludvik, J ., and O. Benada. 1985. New bacteriophage-like 
pdXiicXQs'mCorynebacterium glutamicum. Virology. Jan 30:140(2):360-363.
22. Grasseehl, H.A., and M.F. Minnick. 1994. Transformation of Bartonella 
6ûcz7/z/ùr/n/.y by electroporation. Can. J. Microbiol. 40:782-786.
23. Sancar, A., and A M. Rupp. 1979. Simple method for identification of 
plasmid-encoded proteins. J. Bacteriol 137:692
24. Altschul, S.F., and W. Gish. 1990. Basic local alignment search tool. J. Mol 
Biol. (215):403-410.
25. Davis, R.W., D. Bostein, and J.R . Roth. 1980. Advanced Bacterial Genetics. 
Cold Springs Harbor Laboratory, Cold Spring Harbor, New York.
47
26. Towbin, H., T. Staehlin, a n d J . Gordon. 1979. Electrophoretic transfer of 
proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some 
applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354.
27. MuUis, K.B., and F.A. Faloona. 1987. Specific synthesis o f D N A v / 7 r o  via 
a polymerase-catalyzed chain reaction. Methods Enzymol. 155:335-350.
28. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. 
Smith, and K. StruhL 1995. Current protocols in molecular biology. Wiley 
and Sons, Inc., New York.
29. Laemmli, U.K. 1970. Cleavage o f structural proteins during the assembly of 
bacteriophage T4. Nature. 227:680-685.
30. Anderson, L.M., and K.F. Bott. 1985. DNA packaging by the 
subtilis defective bacteriophage PBSX. J. Virol. 54:773-780.
31. Humphrey, S.B., T.B. Stanton, N.S. Jensen, and R.L. Zuemer. 1997. 
Purification and characterization o f VSH-1, a generalized transducing 
\)SiCtQno^\[a%QoiSerpulinahyodysenteriae. J. Bacteriol. 179:323-329.
32. Minnick, M.F. 1997. Virulence determinants o f  Bûr/o«e//a Pg. 
197-211. Rickettsial Infection and Immunity^ edited by Anderson et al. Plenum 
Press, New York.
33. Lang, Andrew and J.T. Beatty. 2000. Genetic analysis of a bacterial genetic 
exchange element: The gene transfer agent of Rhodobacter capsulatus. PNAS. 
97:859-864.
34. Brock, T.D., M.T. Madigan, J.M . M artinko, and J. Parker. 1997. Biology 
o f Microorganisms, S**’ ed. Prentice Hall, Englewood Clife, New Jersey.
48
35. Verma, A., Davis G.E., and G.M. Ihler. 2001. Formation o f stress fibres in 
human endothelial cells infected with Bartonella bacilliformis is associated with 
altered morphology, impaired migration and defects in cell morphogenesis. Cell 
Microbiol. 3(3):169-180.
36. Verma, A., Davis, G.E., and G.M. Ihler. 2000. Infection o f human 
endothelial cells with Bartonella bacilliformis is dependent on Rho and results 
in activation o f Rho. Infect Immun. 68(10):5960-5969.
37. Koehler, J.E . 1996. Bartonella mScciiom. Pg. 1-27. Advances in Pediatric 
Infectious Diseases. Vol 11. Mosby-Year Book, Inc. San Francisco, California.
38. Raouit, D., P.E. Fournier, M. Drancourt, T.J. M arrie, J. Etienne, J. 
Cosserat, P. Cacoub, Y. Poinsignon, P. Leclercq, and A M, Sefton. 1996. 
Diagnosis o f 22 new cases of Bartonella endocarditis. Ann Intern. Med. 
125:646-652.
39. Jackson, L. A. and D.H. Spach. 1996. o f  Bartonella quintana
infection among homeless persons. Emerg. Infect. Dis. 2:141-144.
40. Mazodier, P. and J. Davies. 1991. Gene transfer between distantly related 
bacteria. Ann Rev. Genet. 25:147-171.
41. Black, Jacquelyn. 1996. Microbiology: Principles and Applications. 3^ 
edition. Prentice Hall, Upper Saddle River, New Jersey.
42. Jawetz, Melnick, and Adelberg. 1998. Medical Microbiology. 21^ ed. 
Appleton and Lange, Stamford, Connecticut.
49
43. Ellis, B., Rotz, D., Olson, J., and Carlos P. Carrillo. 1998. An outbreak of 
acute bartonellosis (Oroya fever) in the Urubamba region o f Peru. Am. J. Trop. 
Med. Hyg. 61(2):344-349.
44. Thompson, J.D., D.G. H i^ n s ,  and T.J. Gibson. 1994. CLUSTALW: 
inç)roving the sensitivity o f progressive multiple sequence alignment through 
sequence weighting, position-specific gap penalties and weight matrix choice. 
Nucleic Acids Res. 22:4673-4680.
45. Pearson, W.R. 1990. Rapid and sensitive sequence comparison with FAST? 
and PASTA. Methods Enzymol. 183:63-98.
46. Wadskov-Hansen, S.L., and K. Hammer. 2000. The pyrH gene of 
Lactococcus lactis subsp. Cremoris encoding UMP kinase is transcribed as part 
o f an operon including the firl gene encoding ribosomal recycling factor 1.
Gene. 241(1):157-166.
47. Lehninger, Albert. 1975. Biochemistry. Second edition. Worth Publishers, 
Inc. New York, N.Y.
48. Kobayashi, Yuji. 2000. Physico-chemical properties o f Ribosome Recycling 
Factor. Non-published. Graduate School o f Pharmaceutical Sciences, Osaka 
University, Osaka, Japan.
49. Rao, A.R., and U. Varshney. 2001. Specific interaction between the ribosome 
recycling fector and the elongation fector G fi’om Mycobacterium tuberculosis 
mediates peptidyl-tRNA release and ribosome recycling in Escherichia coli. 
EMBO. 20(ll):2977-2986.
50
50. Ohnishi, M., Janoshi, L., Matsumoto, H., and A. Kaji. 1999. Molecular 
cloning, sequencing, purification, and characterization o f Pseudomonas
ribosome recycling fector. J Bacteriol. 181(4):1281-1291.
51. Struyve, M., M. Moons, and J. Tommassen. 1991. Carboxyl-terminal 
phenylalanine is essential for the correct assembly of a bacterial outer membrane 
protein. J. Mol. Biol. 218:141-148.
51
